Dr Lauren Byrne

Here's an open access link to full text of our paper shared last week! rdcu.be/evKF9

UCL Queen Square Institute of Neurology ready to (platform) party this morning! @uclqsion.bsky.social

Huge congratulations to all of our graduates from the @uclbrainscience.bsky.social & wishing you all every success for the future! #UCLgrad

Important paper on accessible biomarkers from @hob-lab.bsky.social. Well done Annabelle Coleman @drl-bo.bsky.social and all.

Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis INTRODUCTION Diagnosing Alzheimer's disease (AD) is challenging due to overlapping symptoms with other dementias and the invasiveness of current biomarkers. This study introduces the NULISA platform...

Happy to have played a small part in testing this next generation of blood biomarker tests across different dementias: Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseases - Journal of Neurology Promising blood-based biomarkers of neuropathology have emerged with potential for therapeutic development and disease monitoring. However, these tools will require specialist tertiary services for in...

New paper from the @hob-lab.bsky.social just published in Journal of Neurology. A step toward more accessible biomarker testing 🩸 link.springer.com/article/10.1... @drl-bo.bsky.social @uclbrainscience.bsky.social @uclqsion.bsky.social

I am unbelievably proud to have my first senior author paper published today! It was a long slog through multiple review cycles but we got there!

A big thank you to my lab members and all the collaborators and participants who contributed to this work! 🥲

Where else are we planning to open HDClarity sites?

We are currently in the process of opening recruitment to the study into other countries, including Melbourne, Australia, and Lisbon, Portugal.

Smartphone tests could accelerate drug development for Huntington’s disease A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials, finds research le...

A series of digital tests carried out via a smartphone app could enhance the detection of disease progression in #HuntingtonsDisease and improve the efficiency of clinical trials, finds research led by scientists at @uclqsion.bsky.social @ucl-hd.bsky.social and Roche including @profwild.bsky.social

A digital motor score for sensitive detection of progression in Huntington’s disease Giboin et al. introduce a new motor score that can be used to monitor Huntington’s disease progression. Co-designed by people with Huntington’s disease and

New paper in BRAIN from Team Wild and Roche: A digital motor score for sensitive detection of progression in Huntington’s disease (open access)

doi.org/10.1093/brai...